Studies in different mammalian species have shown that FOXRED1 expression increases rapidly during embryonic development (17), and proinflammatory conditions during pregnancy, such as IUGR and preeclampsia, can dramatically increase ROS production, placing even higher demands on the oxidative stress defense systems (18). This evidence concerns the gene FOXRED1 and fetal growth restriction.